Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 7
2018 3
2019 3
2020 4
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review.
von Hardenberg J, Schwartz M, Werner T, Fuxius S, Strauss A, Worst TS, Nuhn P, Bolenz C, Heinrich E. von Hardenberg J, et al. Among authors: worst ts. Urol Int. 2017;99(4):414-421. doi: 10.1159/000477943. Epub 2017 Jul 13. Urol Int. 2017. PMID: 28700990 Review.
FOXM1 predicts disease progression in non-muscle invasive bladder cancer.
Rinaldetti S, Wirtz R, Worst TS, Hartmann A, Breyer J, Dyrskjot L, Erben P. Rinaldetti S, et al. Among authors: worst ts. J Cancer Res Clin Oncol. 2018 Sep;144(9):1701-1709. doi: 10.1007/s00432-018-2694-5. Epub 2018 Jun 29. J Cancer Res Clin Oncol. 2018. PMID: 29959570 Free PMC article.
19 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page